Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Jupiter Neurosciences, Inc. (JUNS) had Return on Equity of -3984.82% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-2.29M |
|
-- |
|
-- |
|
$2.30M |
|
$-2.30M |
|
$0.01M |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
$-2.30M |
|
$-2.30M |
|
34.04M |
|
34.04M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$1.63M |
|
-- |
|
$0.94M |
|
$2.58M |
|
$2.52M |
|
-- |
|
-- |
|
$2.52M |
|
$0.06M |
|
$0.06M |
|
$0.06M |
|
34.30M |
|
| Cash Flow Statement Financials | |
$-3.05M |
|
-- |
|
-- |
|
$3.77M |
|
$0.72M |
|
$-3.05M |
|
$1.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.65 |
|
-- |
|
-- |
|
-- |
|
2.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-3984.82% |
-3984.95% |
|
-88.81% |
|
-3984.94% |
|
$0.00 |
|
$-0.09 |
|
$-0.09 |
|